Neuronostics

Neuronostics is transforming neurological healthcare through advanced digital biomarkers and mathematical modelling. The company develops innovative tools that enhance the diagnostic power of EEG, enabling faster and more accurate identification of epilepsy and other neurological conditions. Its flagship technology, BioEP, provides clinicians with objective insights by analysing routine EEG data to predict seizure likelihood and support decision-making. Founded by leading experts in computational neuroscience, Neuronostics combines scientific excellence with practical solutions to reduce diagnostic uncertainty and improve patient outcomes. With a vision to make digital biomarkers a standard in neurology, Neuronostics is driving a proactive and anticipatory model of care that radically improves lives.